INIS BIOTECH LLC
20Patents
20Active
20Granted
51Portfolio score
Filing activity: Nov 14, 2007 → Feb 4, 2020 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9657298B2 | Recombinant nitrogen-fixing bacterial strain, inoculum containing the same and application methods | Chemistry; Metallurgy | 24 | Active |
| US8206440B2 | Implantable ocular microapparatus to ameliorate glaucoma or an ocular overpressure causing disease | Human Necessities | 24 | Active |
| US9733174B2 | Capillary microviscometer | Physics | 2 | Active |
| US10385114B2 | SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure | Chemistry; Metallurgy | 0 | Active |
| US10233227B2 | Isoform of the TGF-beta receptor II | Chemistry; Metallurgy | 0 | Active |
| US11835665B2 | Neutron and gamma radiation detector using a water Cherenkov detector | Physics | 0 | Active |
| US10490866B2 | Method for acid dissolution of LiCoO2 contained in spent lithium-ion batteries | Emerging Cross-Sectional Technologies | 0 | Active |
| US11072647B2 | TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro | Physics | 0 | Active |
| US10857522B2 | Catalytic process for the production of propylene glycol from glycerol, a copper and cerium catalyst, and a process to produce such catalyst | Performing Operations; Transporting | 0 | Active |
| US10259719B2 | Process for obtaining lithium from aluminosilicates and intermediate compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8431554B2 | Compound showing anti-inflammatory activity and antiviral activity, pharmaceutical compositions comprising the same, a process for obtaining the same and use of the same in the treatment of epidemic keratoconjunctivites and herpetic stromal keratis | Chemistry; Metallurgy | 0 | Active |
| US8993310B2 | Device for diagnosis of physiologic status and/or selection of the best spermatozoa of a semen sample based on chemotaxis, and procedure of use thereof | Physics | 0 | Active |
| US9623102B2 | Vaccines for the prevention of infections with Bordetella | Human Necessities | 0 | Active |
| US11020478B2 | Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment | Chemistry; Metallurgy | 0 | Active |
| US10294295B2 | Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment | Chemistry; Metallurgy | 0 | Active |
| US8195404B2 | Small organism locomotor recording procedure and device, behavioral record obtained and use of same | Human Necessities | 0 | Active |
| US10000548B2 | GAL-1 variants having immuno-modulating properties and methods of using the same | Human Necessities | 0 | Active |
| US9511137B2 | Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof | Human Necessities | 0 | Active |
| US9187518B2 | Antiangiogenic brassinosteroid compounds | Human Necessities | 0 | Active |
| US8541566B2 | Promoter inducible by reactive oxygen species and vector comprising the same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.